MedTrace Logo

Easytech Reversed Shoulder System Clinical Study

NCT03806842 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-09-28

No results posted yet for this study

Summary

The purpose of the study is to collect data to demonstrate the safety and effectiveness of the Easytech Reversed Shoulder System for the treatment of patients who require a reverse total shoulder arthroplasty.

Conditions

  • Osteo Arthritis Shoulders
  • Avascular Necrosis of the Head of Humerus
  • Rotator Cuff Tear

Interventions

DEVICE

Easytech group

total shoulder replacement

Sponsors & Collaborators

  • FX Shoulder Solutions

    lead INDUSTRY

Principal Investigators

  • Kathy Trier, PhD · FX Shoulder Solutions

  • Brian Rogers, BS · FX Shoulder Solutions

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-28
Primary Completion
2024-12-28
Completion
2024-12-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03806842 on ClinicalTrials.gov